Network Meta-Analysis Compares DOACs to LMWH for Cancer-Linked Thrombosis

TUESDAY, Dec. 27, 2022 -- Direct oral anticoagulants (DOACs) are more effective and cost-effective than low-molecular-weight heparin for cancer-associated thrombosis (CAT), with the results sensitive to monthly drug costs, according to research...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news